Investment Opportunities: Golf Entertainment Company Paying 8% Dividend; Non-Addictive Painkiller Biotech; Build-to-Rent Home Builder With 8% Dividend
Reg A+ offerings — Anyone can invest
GolfSuites 1 — Anyone can invest
“GolfSuites is a new investment opportunity focused on bringing hybrid-golf centers for year-round play, entertainment and game improvement, to millions of people nationwide, in a friendly environment.”
- Minimum investment $500
- 8% annual dividend paid monthly
- Likely tax-free for several years
- Favorable long-term golf market trends
- Experienced management
- Sizable Real Estate exposure in land and improvements
InSitu Biologics — Anyone can invest
“An emerging biotech company focusing on development of AnestaGel™, a long-lasting and long-acting non-opiate painkiller.”
- Minimum investment $2,460
- Already raised more than $3.4 million
- They intend to expand into the animal market with their new AniGel™ Product
- The offering is closing on November 30, 2019
Exclusive offerings only for Accredited Investors
ERC Homebuilders (Parent of ERC South Florida) — for Accredited Investors only
“ERC is building “build-to-rent” homes to capitalize on market demand driven by the cultural wave of millennials who seek single-family living, without the costs of buying their home.”
- Pays 8% dividend /year — paid monthly
- Favorable real estate market trends for Build-To-Rent Real Estate
- Experienced management
- Florida Focus
- Minimum investment $10k
KGEM Golf (Parent of Golf Suites 1) — for Accredited Investors only
- Pays 8% dividend /year — paid monthly
- Likely tax-free for several years
- Experienced management
- Sizable Real Estate exposure in land and improvements nationwide.
- Exclusive offering for Accredited Investors
- Minimum investment $10k
This was first published as a blog on on manhattanstreetcapital.com.
See the Manhattan Street Capital terms for the offerings above
We are paid to promote these offerings.
Please read our important investor warnings here
Rod Turner is the founder and CEO of Manhattan Street Capital, the #1 Growth Capital marketplace for mature startups and mid-sized companies to raise capital using Regulation A+. Turner has played a key role in building successful companies including Symantec/Norton (SYMC), Ashton Tate, MicroPort, Knowledge Adventure and more. He is an experienced investor who has built a Venture Capital business (Irvine Ventures) and has made angel and mezzanine investments in companies such as Bloom, Amyris (AMRS), Ask Jeeves and eASIC.
